Elite Pharmaceuticals, Inc. (QB) Stock Price - ELTP

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 0.20 ▲ 0.00 (1.34%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Elite Pharmaceuticals, Inc. (QB) ELTP Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00335 +1.73% 0.19735 0.2 0.186 0.2 0.194 16:00:00
Bid Price Ask Price Spread Spread % News
0.19 0.2 0.01 5.00% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
134 1,544,163 $ 0.1958 $ 302.37k 963.29k 0.11 - 0.40
Last Trade Time Type Quantity Stock Price Currency
16:00:11 formt 25,000 $0.20 USD

Elite Pharmaceuticals, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 181.15M 917.9M $ -683.01k - -265.22 593.92M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
11.12k 0.00% $ - 0.00% - -

more financials information »

Elite Pharmaceuticals, Inc. (QB) News

Latest ELTP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.2370.24450.17690.00001M4M2M-0.03965-16.73%
1 Month0.145970.24950.1430.0000415k4M2M0.0513835.20%
3 Months0.130350.24950.1250.0000192k4M951k0.06751.40%
6 Months0.140.24950.1250.0000192k5M1M0.0573540.96%
1 Year0.320.3950.110.0000107k20M1M-0.12265-38.33%
3 Years0.3930.46550.110.0000020M1M-0.19565-49.78%
5 Years0.11710.970.00010.0000029M2M0.0802568.53%

Elite Pharmaceuticals, Inc. (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International. Elite currently has eight commercial products being sold, additional approved products pending manufacturing site transfer and the NDA for SequestOx, for which it received the CRL from the FDA. Elite's lead pipeline products include abuse-deterrent opioids which utilize the Company's patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.